Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Ternatin 4
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Tomivosertib
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Pevonedistat
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
PS3061
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
RS-PPCC
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
MZ1
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
PB28
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
PD-144418
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
JQ1
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Merimepodib
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
GB110
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
H-89
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
IHVR-19029
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
CPI-0610
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
DBET6
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
E-52862
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
AZ3451
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
AZ8838
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
CCT 365623
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Compound 10
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020